Vita 34 AG
XETRA:V3V
Vita 34 AG
Net Issuance of Debt
Vita 34 AG
Net Issuance of Debt Peer Comparison
Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vita 34 AG
XETRA:V3V
|
Net Issuance of Debt
-€10.8m
|
CAGR 3-Years
-71%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
-20%
|
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
Net Issuance of Debt
-€1.6B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-37%
|
Fresenius SE & Co KGaA
XETRA:FRE
|
Net Issuance of Debt
-€410m
|
CAGR 3-Years
35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
E
|
Euroeyes International Eye Clinic Ltd
HKEX:1846
|
Net Issuance of Debt
-HK$59.3m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
Synlab AG
XETRA:SYAB
|
Net Issuance of Debt
-€660.2m
|
CAGR 3-Years
-81%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vita 34 AG's Net Issuance of Debt?
Net Issuance of Debt
-10.8m
EUR
Based on the financial report for Dec 31, 2023, Vita 34 AG's Net Issuance of Debt amounts to -10.8m EUR.
What is Vita 34 AG's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 10Y
-20%
Over the last year, the Net Issuance of Debt growth was -20%. The average annual Net Issuance of Debt growth rates for Vita 34 AG have been -71% over the past three years , -40% over the past five years , and -20% over the past ten years .